Adjuvant chemotherapy for stage II (Dukes' B) colon cancer: Too early for routine use

European Journal of Surgical Oncology

Volumn 26, Issue 8, 2000, Pages 730-732

  Wein, A ^a,b   Hahn, E G ^a,b   Merkel, S ^a,b   Hohenberger, W ^a,b  

^a UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; FLUOROURACIL; FOLINIC ACID;

CANCER ADJUVANT THERAPY; CANCER STAGING; CANCER SURVIVAL; CLINICAL TRIAL; COLON CANCER; DIARRHEA; HUMAN; LEUKOPENIA; PRIORITY JOURNAL; PROGNOSIS; SHORT SURVEY; STOMATITIS;

EID: 0034522246     PISSN: 07487983     EISSN: None     Source Type: Journal    
DOI: 10.1053/ejso.2000.0993     Document Type: Short Survey

References (30)

1. Comparative efficacy of adjuvant chemotherapy in patients with Dukes' B versus Dukes' C colon cancer: Results from four national surgical adjuvant breast and bowel project adjuvant studies (C-01, C-02, C-03, and C-04)
2. Efficacy of adjuvant fluorouracil and folinic acid in B2 colon cancer
3. Adjuvant portal-vein infusion of fluorouracil and heparin in colorectal cancer: A randomised trial
4. Randomized trial of adjuvant perioperative chemotherapy in radically resected colorectal cancer (SAKK 40/87)
5. Portal vein chemotherapy for colorectal cancer: A meta-analysis of 4000 patients in 10 studies
6. Long-term results of single course of adjuvant intraportal chemotherapy for colorectal cancer
7. Langzeitergebnisse der chirurgischen therapie des coloncarzinoms
8. Postoperative adjuvant chemotherapy or BCG for colon cancer: Results from NSABP protocol C-01
9. Adjuvant therapy of Dukes' A, B, and C adenocarcinoma of the colon with portal-vein fluorouracil hepatic infusion: Preliminary results of National Surgical Adjuvant Breast and Bowel Project Protocol C-02
10. The benefit of leucovorin-modulated fluorouracil as postoperative adjuvant therapy for primary colon cancer: Results from National Surgical Adjuvant Breast and Bowel ProJect Protocol C-03
11. Clinical trial to assess the relative efficacy of fluorouracil and leucovorin, fluorouracil and levamisole and fluorouracil, leucovorin, and levamisole in patients with Dukes B and C carcinoma of the colon: Results from National Surgical Adjuvant Breast and Bowel Project C-04
12. Efficacy of adjuvant fluorouracil and folinic acid in colon cancer
13. American Joint Committee on Cancer Prognostic Factors Consensus Conference
14. Colorectal carcinoma
15. Molecular prognostic markers and colorectal cancer: The search goes on
16. Micrometastases and survival in stage II colorectal cancer
17. Recommendations for the reporting of resected large intestinal carcinoma
18. For patients with Dukes' B (TNM Stage II) colorectal carcinoma, examination of six or fewer lymph nodes is related to poor prognosis
19. Colon cancer survival is associated with increasing number of lymph nodes removed. A secondary analysis of INT-0089
20. Grundlagen und wert der lymphadenektomie beim colorektalen carcinom
21. Risk groups for distant metastases in colon cancer stage II
22. Prospectively randomized trial of postoperative adjuvant chemotherapy in patients with high-risk colon cancer
23. Adjuvant 5-fluorouracil and leucovorin with or without interferon alfa-2a in colon carcinoma: National Surgical Adjuvant Breast and Bowel Project Protocol C-05
24. Cardiotoxicity of 5-fluorouracil in combination with folinic acid in patients with gastrointestinal cancer
25. Toxicity report of a phase III trial (GERCOR C96.1) comparing bimonthly LV5FU2 to monthly 5FU-leucovorin high dose (LV HD) in patients with Dukes' B and C colon cancer
26. Weekly 24-h-infusion of high-dose 5-fluorouracil (5-FU) 24-h-infusion with folinic acid (FA) in adjuvant treatment of colon cancer
27. Multicentre phase III open label randomised trial comparing CPT-11 in combination with a 5-FU/FA infusional regimen to the same 5-FU/FA infusional regimen alone as adjuvant treatment for stage II and III colon cancer
28. Multicenter international study of oxaliplatin/5 FU-LV in the adjuvant treatment of colon cancer
29. Clinicopathological staging for colorectal cancer: An International Documentation System (IDS) and an International Comprehensive Anatomical Terminology (ICAT)